PSA4_HUMAN - dbPTM
PSA4_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PSA4_HUMAN
UniProt AC P25789
Protein Name Proteasome subunit alpha type-4
Gene Name PSMA4
Organism Homo sapiens (Human).
Sequence Length 261
Subcellular Localization Cytoplasm . Nucleus . Colocalizes with TRIM5 in the cytoplasmic bodies.
Protein Description Component of the 20S core proteasome complex involved in the proteolytic degradation of most intracellular proteins. This complex plays numerous essential roles within the cell by associating with different regulatory particles. Associated with two 19S regulatory particles, forms the 26S proteasome and thus participates in the ATP-dependent degradation of ubiquitinated proteins. The 26S proteasome plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins that could impair cellular functions, and by removing proteins whose functions are no longer required. Associated with the PA200 or PA28, the 20S proteasome mediates ubiquitin-independent protein degradation. This type of proteolysis is required in several pathways including spermatogenesis (20S-PA200 complex) or generation of a subset of MHC class I-presented antigenic peptides (20S-PA28 complex)..
Protein Sequence MSRRYDSRTTIFSPEGRLYQVEYAMEAIGHAGTCLGILANDGVLLAAERRNIHKLLDEVFFSEKIYKLNEDMACSVAGITSDANVLTNELRLIAQRYLLQYQEPIPCEQLVTALCDIKQAYTQFGGKRPFGVSLLYIGWDKHYGFQLYQSDPSGNYGGWKATCIGNNSAAAVSMLKQDYKEGEMTLKSALALAIKVLNKTMDVSKLSAEKVEIATLTRENGKTVIRVLKQKEVEQLIKKHEEEEAKAEREKKEKEQKEKDK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSRRYDSRT
------CCCCCCCCC
26.0126074081
5Phosphorylation---MSRRYDSRTTIF
---CCCCCCCCCEEE
19.7028555341
7Phosphorylation-MSRRYDSRTTIFSP
-CCCCCCCCCEEECC
23.6930622161
9PhosphorylationSRRYDSRTTIFSPEG
CCCCCCCCEEECCCC
28.3523927012
10PhosphorylationRRYDSRTTIFSPEGR
CCCCCCCEEECCCCC
20.9323927012
13PhosphorylationDSRTTIFSPEGRLYQ
CCCCEEECCCCCEEE
20.4219664994
54AcetylationAERRNIHKLLDEVFF
HHHCCHHHHHHHHHH
47.1225953088
54UbiquitinationAERRNIHKLLDEVFF
HHHCCHHHHHHHHHH
47.1221890473
542-HydroxyisobutyrylationAERRNIHKLLDEVFF
HHHCCHHHHHHHHHH
47.12-
56AcetylationRRNIHKLLDEVFFSE
HCCHHHHHHHHHHCH
6.6919608861
56UbiquitinationRRNIHKLLDEVFFSE
HCCHHHHHHHHHHCH
6.6919608861
62PhosphorylationLLDEVFFSEKIYKLN
HHHHHHHCHHHHHCC
26.9021712546
64UbiquitinationDEVFFSEKIYKLNED
HHHHHCHHHHHCCCC
50.5721890473
642-HydroxyisobutyrylationDEVFFSEKIYKLNED
HHHHHCHHHHHCCCC
50.57-
67UbiquitinationFFSEKIYKLNEDMAC
HHCHHHHHCCCCCCC
48.5921906983
72SulfoxidationIYKLNEDMACSVAGI
HHHCCCCCCCHHHCC
3.1030846556
74GlutathionylationKLNEDMACSVAGITS
HCCCCCCCHHHCCCC
2.4222555962
75PhosphorylationLNEDMACSVAGITSD
CCCCCCCHHHCCCCC
12.8820068231
80PhosphorylationACSVAGITSDANVLT
CCHHHCCCCCHHHHH
21.4520068231
81PhosphorylationCSVAGITSDANVLTN
CHHHCCCCCHHHHHH
32.5720068231
87PhosphorylationTSDANVLTNELRLIA
CCCHHHHHHHHHHHH
23.5120068231
105UbiquitinationLLQYQEPIPCEQLVT
HHHCCCCCCHHHHHH
6.3219608861
105AcetylationLLQYQEPIPCEQLVT
HHHCCCCCCHHHHHH
6.3219608861
105UbiquitinationLLQYQEPIPCEQLVT
HHHCCCCCCHHHHHH
6.3221890473
121PhosphorylationLCDIKQAYTQFGGKR
HHHHHHHHHHHCCCC
9.8928152594
122PhosphorylationCDIKQAYTQFGGKRP
HHHHHHHHHHCCCCC
22.0428152594
127UbiquitinationAYTQFGGKRPFGVSL
HHHHHCCCCCCCEEE
58.2219608861
127SumoylationAYTQFGGKRPFGVSL
HHHHHCCCCCCCEEE
58.2219608861
127AcetylationAYTQFGGKRPFGVSL
HHHHHCCCCCCCEEE
58.2219608861
128UbiquitinationYTQFGGKRPFGVSLL
HHHHCCCCCCCEEEE
34.7521890473
134UbiquitinationKRPFGVSLLYIGWDK
CCCCCEEEEEEEECC
3.8021890473
139UbiquitinationVSLLYIGWDKHYGFQ
EEEEEEEECCCCCEE
11.2621890473
143PhosphorylationYIGWDKHYGFQLYQS
EEEECCCCCEEEEEC
25.94-
148PhosphorylationKHYGFQLYQSDPSGN
CCCCEEEEECCCCCC
8.6629496907
156PhosphorylationQSDPSGNYGGWKATC
ECCCCCCCCCEEEEE
22.1229496907
160SumoylationSGNYGGWKATCIGNN
CCCCCCEEEEEECCC
36.77-
160UbiquitinationSGNYGGWKATCIGNN
CCCCCCEEEEEECCC
36.77-
160AcetylationSGNYGGWKATCIGNN
CCCCCCEEEEEECCC
36.7768717
160UbiquitinationSGNYGGWKATCIGNN
CCCCCCEEEEEECCC
36.7721890473
162PhosphorylationNYGGWKATCIGNNSA
CCCCEEEEEECCCHH
10.8321406692
167UbiquitinationKATCIGNNSAAAVSM
EEEEECCCHHHHHHH
28.0119608861
167UbiquitinationKATCIGNNSAAAVSM
EEEEECCCHHHHHHH
28.0121890473
167AcetylationKATCIGNNSAAAVSM
EEEEECCCHHHHHHH
28.0119608861
168PhosphorylationATCIGNNSAAAVSML
EEEECCCHHHHHHHH
24.2421406692
173PhosphorylationNNSAAAVSMLKQDYK
CCHHHHHHHHHCCHH
17.4225159151
174SulfoxidationNSAAAVSMLKQDYKE
CHHHHHHHHHCCHHH
4.3321406390
176AcetylationAAAVSMLKQDYKEGE
HHHHHHHHCCHHHCC
32.2619608861
176UbiquitinationAAAVSMLKQDYKEGE
HHHHHHHHCCHHHCC
32.2621890473
180SuccinylationSMLKQDYKEGEMTLK
HHHHCCHHHCCCCHH
68.4823954790
180AcetylationSMLKQDYKEGEMTLK
HHHHCCHHHCCCCHH
68.4825953088
180UbiquitinationSMLKQDYKEGEMTLK
HHHHCCHHHCCCCHH
68.48-
187UbiquitinationKEGEMTLKSALALAI
HHCCCCHHHHHHHHH
25.2321906983
188PhosphorylationEGEMTLKSALALAIK
HCCCCHHHHHHHHHH
31.4623312004
1952-HydroxyisobutyrylationSALALAIKVLNKTMD
HHHHHHHHHHHCCCC
34.75-
195AcetylationSALALAIKVLNKTMD
HHHHHHHHHHHCCCC
34.7525953088
195UbiquitinationSALALAIKVLNKTMD
HHHHHHHHHHHCCCC
34.75-
199AcetylationLAIKVLNKTMDVSKL
HHHHHHHCCCCHHHH
40.8526822725
199UbiquitinationLAIKVLNKTMDVSKL
HHHHHHHCCCCHHHH
40.8521890473
2052-HydroxyisobutyrylationNKTMDVSKLSAEKVE
HCCCCHHHHCHHHEE
46.43-
205UbiquitinationNKTMDVSKLSAEKVE
HCCCCHHHHCHHHEE
46.4321906983
205AcetylationNKTMDVSKLSAEKVE
HCCCCHHHHCHHHEE
46.4325953088
207PhosphorylationTMDVSKLSAEKVEIA
CCCHHHHCHHHEEEE
37.8126091039
210UbiquitinationVSKLSAEKVEIATLT
HHHHCHHHEEEEEEE
44.9021890473
210AcetylationVSKLSAEKVEIATLT
HHHHCHHHEEEEEEE
44.9023749302
215PhosphorylationAEKVEIATLTRENGK
HHHEEEEEEEECCCE
34.0321406692
217PhosphorylationKVEIATLTRENGKTV
HEEEEEEEECCCEEE
31.4221406692
222UbiquitinationTLTRENGKTVIRVLK
EEEECCCEEEEEEEC
51.72-
222AcetylationTLTRENGKTVIRVLK
EEEECCCEEEEEEEC
51.7225953088
223PhosphorylationLTRENGKTVIRVLKQ
EEECCCEEEEEEECH
23.67-
229UbiquitinationKTVIRVLKQKEVEQL
EEEEEEECHHHHHHH
57.37-
231UbiquitinationVIRVLKQKEVEQLIK
EEEEECHHHHHHHHH
63.2421890473
231MalonylationVIRVLKQKEVEQLIK
EEEEECHHHHHHHHH
63.2426320211
231AcetylationVIRVLKQKEVEQLIK
EEEEECHHHHHHHHH
63.2423749302
238UbiquitinationKEVEQLIKKHEEEEA
HHHHHHHHHHHHHHH
57.5821906983
238AcetylationKEVEQLIKKHEEEEA
HHHHHHHHHHHHHHH
57.5819608861
246UbiquitinationKHEEEEAKAEREKKE
HHHHHHHHHHHHHHH
54.802190698

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PSA4_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PSA4_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PSA4_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PLK1_HUMANPLK1physical
11205743
CUL1_HUMANCUL1physical
16759355
PSA6_HUMANPSMA6physical
16759355
PRKN_RATPark2physical
15987638
PRKN_HUMANPARK2physical
15987638
PSA7_HUMANPSMA7physical
15225636
PSA3_HUMANPSMA3physical
15225636
PSA5_HUMANPSMA5physical
15225636
PSA6_HUMANPSMA6physical
15225636
PSA2_HUMANPSMA2physical
14733938
PSA3_HUMANPSMA3physical
14733938
PSA7_HUMANPSMA7physical
14733938
PSA1_HUMANPSMA1physical
9311996
PSA2_HUMANPSMA2physical
9311996
PSA3_HUMANPSMA3physical
9311996
PSA5_HUMANPSMA5physical
9311996
PSA6_HUMANPSMA6physical
9311996
PSA7_HUMANPSMA7physical
9311996
PSB1_HUMANPSMB1physical
9311996
PSB4_HUMANPSMB4physical
9311996
PSB5_HUMANPSMB5physical
9311996
PSB6_HUMANPSMB6physical
9311996
PSB7_HUMANPSMB7physical
9311996
PSB8_HUMANPSMB8physical
9311996
PSB9_HUMANPSMB9physical
9311996
IKBA_HUMANNFKBIAphysical
9875328
NFKB1_HUMANNFKB1physical
8692272
PSA7_HUMANPSMA7physical
17948026
PSB8_HUMANPSMB8physical
15303969
PSA6_HUMANPSMA6physical
22939629
PSA5_HUMANPSMA5physical
22939629
PSA7_HUMANPSMA7physical
22939629
PSB7_HUMANPSMB7physical
22939629
PSB1_HUMANPSMB1physical
22939629
PSB2_HUMANPSMB2physical
22939629
PSB3_HUMANPSMB3physical
22939629
PSB4_HUMANPSMB4physical
22939629
PSB5_HUMANPSMB5physical
22939629
PSB6_HUMANPSMB6physical
22939629
PSB8_HUMANPSMB8physical
22939629
PSMD1_HUMANPSMD1physical
22939629
PSMD2_HUMANPSMD2physical
22939629
PSMD8_HUMANPSMD8physical
22939629
PSMD7_HUMANPSMD7physical
22939629
PSD12_HUMANPSMD12physical
22939629
PSD13_HUMANPSMD13physical
22939629
PSMD6_HUMANPSMD6physical
22939629
PSD11_HUMANPSMD11physical
22939629
PSMD4_HUMANPSMD4physical
22939629
PSDE_HUMANPSMD14physical
22939629
PSME3_HUMANPSME3physical
22939629
PSMD3_HUMANPSMD3physical
22939629
PSMD5_HUMANPSMD5physical
22939629
PSA7L_HUMANPSMA8physical
22939629
USP9X_HUMANUSP9Xphysical
22939629
YBOX1_HUMANYBX1physical
22939629
TERA_HUMANVCPphysical
22939629
AP3M1_HUMANAP3M1physical
22863883
PSA2_HUMANPSMA2physical
22863883
PSA5_HUMANPSMA5physical
22863883
PSB2_HUMANPSMB2physical
22863883
PSB3_HUMANPSMB3physical
22863883
PSB5_HUMANPSMB5physical
22863883
PSME4_HUMANPSME4physical
22863883
P5CR3_HUMANPYCRLphysical
22863883
IKZF1_HUMANIKZF1physical
25416956
CCAR2_HUMANCCAR2physical
26344197
ELP6_HUMANELP6physical
26344197
EXOS4_HUMANEXOSC4physical
26344197
EXOS5_HUMANEXOSC5physical
26344197
PSA3_HUMANPSMA3physical
26344197
PSB3_HUMANPSMB3physical
26344197
PRS8_HUMANPSMC5physical
26344197
PRS10_HUMANPSMC6physical
26344197
PSD13_HUMANPSMD13physical
26344197
PSDE_HUMANPSMD14physical
26344197
PSMD3_HUMANPSMD3physical
26344197
PSMD7_HUMANPSMD7physical
26344197
PSMD8_HUMANPSMD8physical
26344197
RAN_HUMANRANphysical
26344197
U2AF2_HUMANU2AF2physical
26344197
TERA_HUMANVCPphysical
26344197
WDR11_HUMANWDR11physical
26344197
HIF1A_HUMANHIF1Aphysical
27918549

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PSA4_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-127; LYS-176 AND LYS-238,AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.
"Mass spectrometric characterization of the affinity-purified human26S proteasome complex.";
Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.;
Biochemistry 46:3553-3565(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-75, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY.

TOP